As the chairman, co-founder and CEO of Renovia, Marc Beer is no stranger to adversity in his career but many people are wondering how the 58-year-old businessman and entrepreneur has managed to stay on top all these years. He recently agreed to chat with Stephen Callahan about how he got to where he is today and where he hopes to go in the future of his career. He first started college in the autumn of 1983 where he realized he wanted to major in business. After graduating with a business degree in the spring of 1987, he then received his first job offer from a company called Abbott working in their sales department as one of their developers. He held this role for about six years before he moved on to Biostar where he worked in their marketing department.
After two years with the company, he accepted a position as the vice president of global marketing at a business known as Genzyme. He worked for the company for about four years before making the conscious decision to start his own business. Headquartered in Cambridge, Viacell was first
established in May of 2000 to analyze the blood stem cells of umbilical cords in order to try and uncover various vaccines and cures for a wide variety of diseases. He decided to go public with the company in 2005 and they had close to 500 employees but, not long afterward, they decided to close up shop and sell the company for a massive $300 million to Perkin Elmer.
Upon completion of the sale, he was all set to move on to his next big entrepreneurial venture but, before he could, there was a tragic death in the family as his wife passed away of a pulmonary embolism at the age of 42. After the funeral, he was forced to step up as the primary parent,
driving them to and from soccer practice, packing their lunches and helping them with schoolwork as per necessary. Two years later, however, his daughter made him realize the business world needed him and he resolved to open a new company called Renovia. Established in 2016, the
company is the brainchild of Dr. Ray Iglesias, Yolanda Lorie, and Beer and is dedicated to developing and producing medical products to help patients who are suffering from various conditions.
This new venture has already been successful as the FDA just approved their first product for public use and they were awarded a $32 million grant continue researching and developing new products. In fact, some of the conditions they are currently attempting to treat affect nearly a
a quarter of the female population nationwide and this includes types of pelvic floor disorders.